Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Orzaks Ilac Ve Kimyanayi Ticaret ASIST:ORZAX -1.41%18 ROC (Joel Greenblatt) % is 72.71% as of Dec. 2025, which is 14% above its 10-year median of 63.66. GuruFocus rates IST:ORZAX with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 1,987 Consumer Packaged Goods companies, Orzaks Ilac Ve Kimyanayi Ticaret AS ranks better than 93.21% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Orzaks Ilac Ve Kimyanayi Ticaret AS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 72.71%.
The historical rank and industry rank for Orzaks Ilac Ve Kimyanayi Ticaret AS's ROC (Joel Greenblatt) % or its related term are showing as below:
IST:ORZAX'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 60.39 Med: 63.66 Max: 72.71
Current: 72.71
During the past 3 years, Orzaks Ilac Ve Kimyanayi Ticaret AS's highest ROC (Joel Greenblatt) % was 72.71%. The lowest was 60.39%. And the median was 63.66%.
IST:ORZAX's ROC (Joel Greenblatt) % is ranked better than 93.21% of 1987
companies
in the Consumer Packaged Goods industry
Industry Median: 12.02
vs IST:ORZAX: 72.71
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Orzaks Ilac Ve Kimyanayi Ticaret AS ROC (Joel Greenblatt) % Chart
Orzaks Ilac Ve Kimyanayi Ticaret AS Annual Data
Trend
Dec23
Dec24
Dec25
ROC (Joel Greenblatt) %
60.39
63.66
72.71
Orzaks Ilac Ve Kimyanayi Ticaret AS Semi-Annual Data
Dec23
Dec24
Dec25
ROC (Joel Greenblatt) %
60.39
63.66
72.71
IST:ORZAX vs KHC, GIS: ROC (Joel Greenblatt) % Comparison
For the Packaged Foods subindustry, Orzaks Ilac Ve Kimyanayi Ticaret AS's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Orzaks Ilac Ve Kimyanayi Ticaret AS ROC (Joel Greenblatt) % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Orzaks Ilac Ve Kimyanayi Ticaret AS's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Orzaks Ilac Ve Kimyanayi Ticaret AS's ROC (Joel Greenblatt) % falls into.
Orzaks Ilac Ve Kimyanayi Ticaret AS ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is one times the annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 72.71% mean?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a ROC (Joel Greenblatt) % of 72.71% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. This is 14% above median its historical median of 63.66. Over the past decade, Orzaks Ilac Ve Kimyanayi Ticaret AS's ROC (Joel Greenblatt) % has ranged from 60.39 to 72.71. According to the industry distribution chart, Orzaks Ilac Ve Kimyanayi Ticaret AS ranks #135 out of 1987 companies in the Consumer Packaged Goods industry, placing it in the top 6.8%.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS's ROC (Joel Greenblatt) % too high?
Orzaks Ilac Ve Kimyanayi Ticaret AS's current ROC (Joel Greenblatt) % of 72.71% is 14% above median its 10-year median of 63.66. Over the past 10 years, this metric has ranged from a low of 60.39 to a high of 72.71. The Consumer Packaged Goods industry median ROC (Joel Greenblatt) % is 12.02. Orzaks Ilac Ve Kimyanayi Ticaret AS's value of 72.71% is 504.9% above this industry median. Based on the distribution chart, Orzaks Ilac Ve Kimyanayi Ticaret AS ranks #135 out of 1987 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Orzaks Ilac Ve Kimyanayi Ticaret AS has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Orzaks Ilac Ve Kimyanayi Ticaret AS's ROC (Joel Greenblatt) % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Orzaks Ilac Ve Kimyanayi Ticaret AS ranks #135 out of 1987 companies for ROC (Joel Greenblatt) %. This places Orzaks Ilac Ve Kimyanayi Ticaret AS in the top 7% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.02. Orzaks Ilac Ve Kimyanayi Ticaret AS's value of 72.71% is 504.9% above this benchmark. Historically, Orzaks Ilac Ve Kimyanayi Ticaret AS's own ROC (Joel Greenblatt) % has ranged from 60.39 to 72.71 over the past decade. While the company's 10-year median is 63.66 vs. the industry median of 12.02, Orzaks Ilac Ve Kimyanayi Ticaret AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Consumer Packaged Goods company?
The median ROC (Joel Greenblatt) % among Consumer Packaged Goods companies is 12.02, based on 1,987 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Orzaks Ilac Ve Kimyanayi Ticaret AS's current ROC (Joel Greenblatt) % of 72.71% is 504.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Orzaks Ilac Ve Kimyanayi Ticaret AS and its competitors. For the Consumer Packaged Goods industry, the median ROC (Joel Greenblatt) % is 12.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Orzaks Ilac Ve Kimyanayi Ticaret AS's current ROC (Joel Greenblatt) % is 72.71%, which is 14% above median its own 10-year median of 63.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Orzaks Ilac Ve Kimyanayi Ticaret AS stock overvalued right now?
Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX) has a current ROC (Joel Greenblatt) % of 72.71%. The current ROC (Joel Greenblatt) % is 72.71%, which is 14% above median its 10-year median of 63.66 and 504.9% above the Consumer Packaged Goods industry median of 12.02. Orzaks Ilac Ve Kimyanayi Ticaret AS's overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Orzaks Ilac Ve Kimyanayi Ticaret AS (IST:ORZAX), the current ROC (Joel Greenblatt) % is 72.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Orzaks Ilac Ve Kimya Sanayi Ticaret AS operates as a sports nutrition brand. Its products are Vitamin Series, Vitamin D Series, Mineral Series, Magnesium Series, Omega 3 Series, Plant Extracts, Immune Series, Probiotic Series, Bone And Joint Series, and Others. The group offers its products under various brands such as Ocean, Day2Day, Imunol, Cosakondrin, Efervit, Bigflor, and Strains.
18GF Score
Get the complete analysis for IST:ORZAX
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:ORZAX has been successfully added to your 
